SpectraCure AB (publ) (STO:SPEC)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0910
+0.0066 (7.82%)
May 25, 2026, 5:29 PM CET
Market Cap51.92M -30.6%
Revenue (ttm)n/a
Net Income-56.08M
EPS-0.20
Shares Out570.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,865
Average Volume1,749,880
Open0.0844
Previous Close0.0844
Day's Range0.0844 - 0.0936
52-Week Range0.0583 - 1.1920
Beta0.32
RSI66.68
Earnings DateMay 27, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden. [Read more]

Sector Healthcare
Founded 2003
Employees 13
Stock Exchange Nasdaq Stockholm
Ticker Symbol SPEC
Full Company Profile

Financial Performance

Financial Statements

News

SpectraCure AB Quarterly report: Q4 2025

SpectraCure AB has published its Q4 2025 quarterly earnings report on February 27, 2026.

3 months ago - Filings

SpectraCure AB Annual report: Q4 2025

SpectraCure AB has published its Q4 2025 annual report on February 27, 2026.

3 months ago - Filings

SpectraCure AB Quarterly report: Q3 2025

SpectraCure AB has published its Q3 2025 quarterly earnings report on November 13, 2025.

6 months ago - Filings

SpectraCure AB Quarterly report: Q2 2025

SpectraCure AB has published its Q2 2025 quarterly earnings report on August 15, 2025.

10 months ago - Filings

SpectraCure AB Quarterly report: Q1 2025

SpectraCure AB has published its Q1 2025 quarterly earnings report on May 28, 2025.

1 year ago - Filings